Clinical trial
Fluocinolone Implant to Treat Macular Degeneration
NCT00008515 · National Eye Institute (NEI), NIH · Completed
Key facts
| NCT number | NCT00008515 |
|---|---|
| Title | Fluocinolone Implant to Treat Macular Degeneration |
| Official title | A Randomized, Prospective Study of Sustained-Release Fluocinolone Acetonide Implant for Choroidal Neovascularization Associated With Age-Related Macular Degeneration |
| Lead sponsor | National Eye Institute (NEI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Choroidal Neovascularization, Macular Degeneration |
| Intervention type | Drug |
| Interventions | Fluocinolone |
| Enrollment | 16 |
| Start date | Jan 1, 2001 |
| Completion | Dec 1, 2001 |
| First posted | Jan 15, 2001 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: